Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Pharmacogenomics. 2013 Sep;14(12):10.2217/pgs.13.131. doi: 10.2217/pgs.13.131

Figure 9. Association of RRM1 SNP rs1042919 with clinical outcome in Caucasian patients enrolled in AML97.

Figure 9

(A) Box plot representing association of rs1042919 with intracellular levels of ara-CTP (nmol/2 × 107 cells) determined at day 1 in Caucasian acute myeloid leukemia (AML) patients. Plots show medians as a line between boxes representing the first and third quartiles; the whiskers represent the range after excluding the outliers. (B) Survival curve for association of rs1042919 with event-free survival in white AML patients. (C) Survival curve for association of rs1042919 with risk of relapse in white AML patients.

Ara-CTP: 1-β-D-arabinofuranosyl-CTP.